IBEX Technologies Inc
XTSX:IBT
IBEX Technologies Inc
XTSX:IBT
Price:
1.44
CAD
Market Closed
Market Cap:
CA$35.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
IBEX Technologies Inc
Net Income (Common)
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
IBEX Technologies Inc
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
IBEX Technologies Inc
XTSX:IBT
|
Net Income (Common)
CA$4m
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Bright Minds Biosciences Inc
CNSX:DRUG
|
Net Income (Common)
-CA$12.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-91%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Net Income (Common)
$287.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
X
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
Net Income (Common)
-$345.9m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
-36%
|
|
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
Net Income (Common)
-CA$38.6m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
|
e
|
enGene Holdings Inc
NASDAQ:ENGN
|
Net Income (Common)
-$117.3m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
IBEX Technologies Inc
Glance View
IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The company is headquartered in Montreal, Quebec. The Company’s subsidiaries also include Technologies IBEX R&D Inc., IBEX Technologies Corporation and Bio-Research Products Inc. (BRP).
IBT
Intrinsic Value
Not Available
See Also
What is IBEX Technologies Inc's Net Income (Common)?
Net Income (Common)
4m
CAD
4m
CAD
Based on the financial report for Oct 31, 2023, IBEX Technologies Inc's Net Income (Common) amounts to 4m CAD.
What is IBEX Technologies Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
57%
57%
Over the last year, the Net Income (Common) growth was 139%. The average annual Net Income (Common) growth rates for IBEX Technologies Inc have been 57% over the past three years .
